[HTML][HTML] International consensus (ICON) on treatment of Ménière's disease

J Nevoux, M Barbara, J Dornhoffer, W Gibson… - European annals of …, 2018 - Elsevier
Objective To present the international consensus for recommendations for Ménière's
disease (MD) treatment. Methods Based on a literature review and report of 4 experts from 4 …

Menière's disease

JM Espinosa-Sanchez, JA Lopez-Escamez - Handbook of clinical …, 2016 - Elsevier
Menière's disease (MD) is a chronic multifactorial disorder of the inner ear characterized by
episodic vestibular symptoms associated with sensorineural hearing loss, tinnitus, and aural …

Chronic symptoms in patients with unilateral vestibular hypofunction: systematic review and meta-analysis

M Karabulut, L Van Laer, A Hallemans… - Frontiers in …, 2023 - frontiersin.org
Objective To systematically evaluate the full spectrum of self-reported chronic symptoms in
patients with unilateral vestibular hypofunction (UVH) and to investigate the effect of …

Meniett device in meniere disease: Randomized, double‐blind, placebo‐controlled multicenter trial

FY Russo, Y Nguyen, D De Seta, D Bouccara… - The …, 2017 - Wiley Online Library
Objective To evaluate the efficacy of portable Meniett low‐pressure pulse generator
(Medtronic Xomed, Jacksonville, FL) in Meniere disease. Study Design Randomized, double …

The pharmacological management of vertigo in Meniere disease

JM Espinosa-Sanchez… - Expert Opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction The term Meniere disease (MD) gathers a set of rare diseases
involving the inner ear characterized by episodic vertigo associated with fluctuating auditory …

Low-dose intratympanic gentamicin administration for unilateral Meniere's disease using a method based on clinical symptomatology: Preliminary results

A Scarpa, M Ralli, C Cassandro, FM Gioacchini… - American Journal of …, 2019 - Elsevier
Purpose There are many therapeutic options for Meniere's disease (MD); intratympanic (IT)
gentamicin has been proposed for intractable cases although controversy about dosage and …

[HTML][HTML] Dietary restriction for the treatment of Meniere's disease

P De Luca, C Cassandro, M Ralli… - Translational …, 2020 - ncbi.nlm.nih.gov
Meniere's disease (MD) is an idiopathic inner ear disorder characterized by spontaneous
recurrent vertigo, fluctuating sensorineural hearing loss (SNHL), aural fullness and tinnitus …

The clinical outcomes after intratympanic gentamicin injection to treat Menière's Disease: a meta-analysis

Y Zhang, J Fu, H Lin, C Shen, X Wang… - Otology & …, 2019 - journals.lww.com
Objectives: In recent decades, intratympanic gentamicin (ITG) has increasingly been used to
treat intractable Menière's disease (MD). We performed a meta-analysis of pooled clinical …

A comparison of endolymphatic shunt surgery and intratympanic gentamicin for meniere's disease

AW Gibson, IJ Moon, JS Golub… - The …, 2020 - Wiley Online Library
Objective To report audiovestibular outcomes following endolymphatic shunt surgery (ELS)
and intratympanic gentamicin injections (ITG) in patients with Meniere's disease (MD). Study …

Intratympanic therapies for Menière's disease

MW Miller, Y Agrawal - Current otorhinolaryngology reports, 2014 - Springer
There are multiple treatment options to consider when managing patients with Menière's
disease. When conservative measures fail to control symptoms of Menière's disease …